Zusammenfassung
Weicht ein Mädchen in seiner Pubertätsentwicklung von der Peergroup ab, so kann dies zu erheblichem Leidensdruck führen. Nicht jede wahrgenommene Abweichung ist jedoch objektivierbar und nicht jede objektivierbare pathologisch. Neben Normvarianten können einer Pubertätstempostörung verschiedene, ganz unterschiedliche Erkrankungen zugrunde liegen. Die Ursachen reichen von „idiopathischen“ Störungen über endokrinologische, immunologische und genetische Erkrankungen, Tumoren bis hin zu psychosomatischen und psychiatrischen Krankheitsbildern. Im Beitrag wird die Abgrenzung einer möglichen Pathologie gegen die – sehr viel häufigeren – Normvarianten erläutert und die Differenzialdiagnosen der wichtigsten abklärungsbedürftigen, therapiepflichtigen Krankheitsbilder dargestellt.
Abstract
Deviation from the peer group in a girl’s pubertal development creates stress in the adolescent. However, not every subjectively perceived deviation is objectively manifest and not every proven deviation is associated with pathology. Besides variations of the norm, a large number of very different disorders can result in alteration of the onset and/or temporal course of pubertal development. These range from “idiopathic” disturbances, endocrinological and immunological diseases, genetic variations, and tumors, to psychosomatic and psychiatric diseases. In this article the emphasis is on distinguishing the more common and non-pathological variations of the norm from the various diseases that require further investigation and consequently treatment.
Literatur
Eckert-Lind C et al (2020) Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis. JAMA Pediatr 174(4):e195881
Bourguignon, Juul (2012) Pediatric and Adolescent Gynaecology. Karger, , S 13
Aksglaede L et al (2009) Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics 123(5):e932–9
Freedman DS et al (2002) Relation of age at menarche to race, time period, and anthropometric dimensions: the Bogalusa Heart Study. Pediatrics 110(4):e43
Adair LS, Gordon-Larsen P (2001) Maturational timing and overweight prevalence in US adolescent girls. Am J Public Health 91(4):642
Ogland B et al (2011) Pubertal development in daughters of women with pre-eclampsia. Arch Dis Child 96(8):740
Ibáñez L, de Zegher F (2006) Puberty after prenatal growth restraint. Horm Res 65(Suppl 3):112–112
Elks CE et al (2010) Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet 42(12):1077–1085
Sulem P et al (2009) Genome-wide association study identifies sequence variants on 6q21 associated with age at menarche. Nat Genet 41(6):734–738
Day FR et al (2017) Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk. Nat Genet 49(6):834–841
Biro FM et al (2013) Onset of breast development in a longitudinal cohort. Pediatrics 132(6):1019
Yang L et al (2017) Adiposity in relation to age at menarche and other reproductive factors among 300 000 Chinese women: findings from China Kadoorie Biobank study. Int J Epidemiol 46(2):502
Vandenbergh JG (1974) Social determinants of the onset of puberty in rodents. J Sex Res 10(3):181–193
Ellis BJ, Garber J (2000) Psychosocial antecedents of variation in girls’ pubertal timing: maternal depression, stepfather presence, and marital and family stress. Child Dev 71(2):485–501
Boynton-Jarrett R, Harville EW (2012) A prospective study of childhood social hardships and age at menarche. Ann Epidemiol 22(10):731–737
Sun Y et al (2017) Childhood social disadvantage and pubertal timing: a national birth cohort from Australia. Pediatrics 139(6):e2016409
Mandel D, Zimlichman E, Mimouni FB, Grotto I, Kreiss Y (2004) Age at menarche and body mass index: a population study. J Pediatr Endocrinol Metab 17(11):1507–1510
Euling SY, Herman-Giddens ME, Lee PA et al (2008) Examination of US puberty timing data from 1940 to 1994 for secular trends: panel findings. Pediatrics 121(3):172–191
Sanyal S, Ray S (2012) Variation in the menstrual characteristics in adolescents of West Bengal. Singapore Med J 49(7):542–550
Adgent MA et al (2012) Early-life soy exposure and age at menarche. Paediatr Perinat Epidemiol 26:163–175
Teilmann G, Petersen JH, Gormsen M et al (2009) Early puberty in internationally adopted girls: hormonal and clinical markers of puberty in 276 girls examined biannually over two years. Horm Res 72(4):236–246
Bourguignon P. [Hrsg.]Management of precocious puberty: food for thought. J Sandoz Satellite Symposium at the 53rd ESPE Meeting. Dublin : s.n., 2014. Precocious puberty: diagnosis and management—to treat or not to treat.
Aksglaede L et al (2009) Recent decline in Age at breast development: the copenhagen puberty study. Pediatrics 123:e932–e939
Marshall WA et al (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291–303
Cabrera SM et al (2014) Age of thelarche and menarche in contemporary US females: a cross-sectional analysis. J Pediatr Endocrinol Metab 27:47–51
Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P (2009) Consensus statement on the use of gonadotropin-releasing hormone analogs in children. Pediatrics 123(4):e752–e762
de Vries L et al (2010) Premature thelarche: age at presentation affects clinical course but not clinical characteristics or risk to progress to precocious puberty. J Pediatr 156(3):466–471
Pin L, Li Y, Chung-Lin Y (2014) Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty. Medicine 93(27):e260
Golden NH, Lanzkowsky L et al (2002) The effect of oestrogen-progestin treatment on bone mineral density in anorexis nervosa. J Pediatr Adolesc Gynaecol 15:135–143
Persani L (2012) Central hypothyroidism: pathogenic, diagnostic, and therapeutic challenges. J Clin Endocrinol Metab 97(9):3068
Daschner M, Philippin B et al (2002) Circulating inhibitor of gonadotropin releasing hormone secretion by hypothalamic neurons in uremia. Kidney Int 62:1582–1590
Eldar-Geva T, Hirsch HJ et al (2013) Management of hypogonadism in adolescent girls and adult women with Prader-Willi syndrome. Am J Med Genet A 161(12):3030–3034
Mattle V, Dörr HG et al (2005) Diagnostik und Therapie der Pubertas tarda bei der Frau. J Reproduktionsmed Endokrinol 2(3):163–172
Harrington J, Palmert MR (2012) Distinguishing constitutional delay of growth and puberty from isolated hypogonadotropic hypogonadism: critical appraisal of available diagnostic tests. J Clin Endocrinol Metab 97(9):3056–3067
Garnett MR, Puget S et al (2007) Craniopharyngeoma. Orphanet J Rare Dis 2:18
Bauchet L, Rigau V et al (2009) Clinical epidemiology for childhood primary central nervous system tumors. J Neurooncol 92(1):87–98
Packer RJ, Cohen BH, Cooney K (2000) Intracranial germ cell tumors. Oncologist 5:312–320
Ranke MB, Dörr HG (2008) Hypogonadismus in der Adoleszenz. Verlag Wissenschaftliche Scripten, Auerbach, S 107–113
Keil MF, Stratakis A (2008) Pituitary tumors in childhood: an update in their diagnosis, treatment and molecular genetics. Expert Rev Neurother 8(4):563–574
Fideleff HL, Boquete HR et al (2009) Prolactinoma in children and adolescents. Horm Res 72:197–205
Latronico AC, Arnhold IJ (2012) Inactivating mutations of the human luteinizing hormone receptor in both sexes. Semin Reprod Med 30(5):382–386
Forges T, Monnier-Barbarino P et al (2006) Pathophysiology of impaired ovarian function in galactosaemia. Hum Reprod Update 12(5):573–584
Persani L, Rosetti R, Cacciatore C (2010) Genes involved in human premature ovarian failure. J Mol Endokrinol 45:257–279
Dixit H et al (2010) Genes governing premature ovarian failure. Reprod Biomed Online 20:724–740
Zhong QBS, Layman LC (2012) Genetic considerations in the patient with Turner Syndrome—45X with or without mosaicism. Fertil Steril 98(4):775–779
Ranke MB, Dörr HG (2008) Hypogonadismus in der Adoleszenz – Therapien zur Optimierung von Feminisierung, Maskulinisierung und Wachstum. Verlag Wissenschaftliche Scripten, Auerbach, S 115–124
Gonzales L, Feldman Witchel S (2012) The patient with turner syndrome: puberty and medical management concerns. Fertil Steril 98(4):780–786
Brougham MFH, Crofton PM et al (2012) Anti-Müllerian hormone is a marker of Gonadotoxicity in pre- and Postpubertal girls treated for cancer: a prospective study. J Clin Endocrinol Metab 97(6):2059–2067
Binder G, Schweizer R, Haber P, Blumenstock G, Braun R (2015) Accuracy of endocrine tests for detecting hypogonadotropic hypogonadism in girls. J Pediatr 167(3):674–678
Nitsche E (2016) Pubertas tarda. Frauenheilkd Up2date 10(2):119–133
Prader A (1975) Delayed adolescence. Clin Endocrinol Metab 4:143–150
Eichenberg C, Brähler E (2007) „Nothing tastes as good as thin feels…“ – Einschätzungen zur Pro-Anorexia-Bewegung im Internet. Psychother Psychosom Med Psychol 57:269–270
Ezri J, Marques-Vidal P, Nydegger A (2012) Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease. Digestion 85:308–319
Skordis N, Kyriakou A (2011) The multifactorial origin of growth failure in thalassaemia. Pediatr Endocrinol Rev 8(Suppl 2):271–277
Trarbach EB, Silveira LG, Latronico LC (2007) Genetic Insights into human isolated gonadotropin deficiency. Pituitary 10:381–391
Kaspers S, Richter-Unruh A et al (2004) Buserelin testing in 70 adolescents with delayed puberty. Horm Res 62(Suppl 2):80
Taher AT, Viprakasit V et al (2013) Treating iron overload in patients with non-transfusion-dependent Thalassemia. Am J Hematol 88(5):409–415
Zemel BS, Kawchak DA et al (2007) Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res 61:607–613
Paris F, Philibert P et al (2007) Primary Amenorrhoea in a 46XY adolescent girl with partial gonadal dysgenesis: identification of a new SRY gene mutation. Fertil Steril 88:e21–e25
Gubbels CS, Kuppens SM et al (2006) Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone. Fertil Steril 19(4):1293.e13–1293.e16
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
E.M. Nitsche gibt an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden vom Autor keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Gisela Gille, Lüneburg
Katrin Schaudig, Hamburg
Anneliese Schwenkhagen, Hamburg
Aktualisierte Version der Originalpublikation von Nitsche EM (2017) Pubertätsstörungen beim Mädchen. Gynäkologe 50:867–878. https://doi.org/10.1007/s00129-017-4137-9
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Nitsche, E.M. Pubertät – Normalität, Normvarianten und Abweichungen. Gynäkologe 54, 626–639 (2021). https://doi.org/10.1007/s00129-021-04852-y
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00129-021-04852-y
Schlüsselwörter
- Vorzeitige Pubertät
- Verspätete Pubertät
- Störungen der körperlichen Entwicklung
- Pubertätsstörung
- Sexuelle Reifung